SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
March 03 2023 - 9:00AM
Business Wire
Pioneer in decentralized digital health data
analytics joins the ranks of OpenAI, Disney, Tiffany & Co., and
more
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company
in the healthcare space, has been named to Fast Company’s
prestigious annual list of the World’s Most Innovative Companies
for 2023.
This year’s list highlights the businesses at the forefront of
their respective industries, paving the way for the innovations of
tomorrow. These companies are setting the standard with some of the
greatest accomplishments of the modern world. In addition to the
World’s 50 Most Innovative Companies, 540 organizations are
recognized across 54 sectors and regions.
“When founding SOPHiA GENETICS, our goal was to create a tech
company whose impact would significantly improve patients’ care,”
said Jurgi Camblong, CEO and Co-Founder of SOPHiA GENETICS. “Our
clients see the value of our collaborative, decentralized platform
that breaks down data silos to provide equal access to knowledge
and capabilities for the advancement of data driven medicine across
the globe.”
Founded in 2011, SOPHiA GENETICS set out to create a world where
every clinician has a multidimensional understanding of diseases by
integrating data and sharing insights for the benefit of patients
across the globe. What began as a research tool for hospitals and
research labs, has since evolved into the SOPHiA DDM™ Platform of
today – a collaborative community of thousands of healthcare
specialists. Since launch, the platform has grown exponentially,
increasing analysis volume at a compound annual growth rate of over
50% since 2016. SOPHiA GENETICS has analyzed more than 1.2 million
genomic profiles to date.
Powered by AI and machine learning, the cloud-based SOPHiA DDM™
Platform was designed to scale, enabling the company to compute
more data, support additional data modalities, expand to new
geographies, and deploy new applications including added
capabilities to longitudinally follow patient’s data while being
treated for cancer. Since its inception in genomics, the SOPHiA
DDM™ Platform has evolved to include the analysis of clinical,
biological, genomic, and radiomic data to support the numerous
ongoing multimodal studies supported by SOPHiA GENETICS. The
company partners with leading global brands in research and
medicine.
Fast Company’s editors and writers sought out the companies
making the biggest strides around the globe. They also judged
nominations received through their application process.
The World’s Most Innovative Companies is Fast Company’s
signature franchise and one of its most highly anticipated
editorial efforts of the year. It provides a firsthand look at the
inspiring and innovative efforts of companies across all sectors of
the economy.
“What a strange and thrilling year it has been to honor this
year’s Most Innovative Companies. This year’s list compiles some of
the most cutting-edge groundbreakers who are changing our world
every single day, from legacy organizations like McDonald’s to
upstarts like MrBeast and institutions such as NASA. Everyone on
this list does something completely, uniquely different, yet, they
all have one thing in common: innovation,” said Fast Company
editor-in-chief Brendan Vaughan.
About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a
software company dedicated to establishing the practice of
data-driven medicine as the standard of care and for life sciences
research. It is the creator of the SOPHiA DDM™ Platform, a
cloud-native platform capable of analyzing data and generating
insights from complex multimodal data sets and different diagnostic
modalities. The SOPHiA DDM™ Platform and related solutions,
products and services are currently used by a broad network of
hospital, laboratory, and biopharma institutions globally. For more
information, visit SOPHiAGENETICS.COM, or connect on Twitter,
LinkedIn, Facebook, and Instagram. Where others see data, we see
answers.
SOPHiA GENETICS products are for Research Use Only and not for
use in diagnostic procedures, unless specified otherwise. The
information in this press release is about products that may or may
not be available in different countries and, if applicable, may or
may not have received approval or market clearance by a
governmental regulatory body for different indications for use.
Please contact support@sophiagenetics.com to obtain the appropriate
product information for your country of residence.
SOPHiA GENETICS Forward-Looking Statements: This press
release contains statements that constitute forward-looking
statements. All statements other than statements of historical
facts contained in this press release, including statements
regarding our future results of operations and financial position,
business strategy, products, and technology, as well as plans and
objectives of management for future operations, are forward-looking
statements. Forward-looking statements are based on our
management’s beliefs and assumptions and on information currently
available to our management. Such statements are subject to risks
and uncertainties, and actual results may differ materially from
those expressed or implied in the forward-looking statements due to
various factors, including those described in our filings with the
U.S. Securities and Exchange Commission. No assurance can be given
that such future results will be achieved. Such forward-looking
statements contained in this press release speak only as of the
date hereof. We expressly disclaim any obligation or undertaking to
update these forward-looking statements contained in this press
release to reflect any change in our expectations or any change in
events, conditions, or circumstances on which such statements are
based, unless required to do so by applicable law. No
representations or warranties (expressed or implied) are made about
the accuracy of any such forward-looking statements.
ABOUT FAST COMPANY Fast Company is the only media brand
fully dedicated to the vital intersection of business, innovation,
and design, engaging the most influential leaders, companies, and
thinkers on the future of business. Headquartered in New York City,
Fast Company is published by Mansueto Ventures LLC, along with our
sister publication Inc., and can be found online at
www.fastcompany.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230303005077/en/
Nick Puleo npuleo@comsint.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024